The exact worldwide prevalence of gastroesophageal reflux disease(GERD)re-mains uncertain,despite its recognition as a common condition.This conundrum arises primarily from the lack of a standardized definition for GE...
BACKGROUND Abnormal gastric acid reflux into the esophagus causes symptoms of gastroeso-phageal reflux disease(GERD)such as heartburn and regurgitation and also leads to mucosal damage.This damage can further lead to ...
Heartburn is a common symptom shared by both gastroesophageal reflux disease(GERD)and functional heartburn(FHB),which can make it challenging to differentiate between the two conditions.However,examining oral manifest...
the University of Szeged Open Access Fund,No.6373.
BACKGROUND Heartburn is identically the key symptom of both,gastroesophageal reflux disease(GERD)and functional heartburn(FHB),making the differential diagnosis resource-intensive.Oral manifestations of GERD can be ea...
Purpose: Ranitidine hydrochloride (HCl) remains an important medication for treating acid-peptic ailments such as Gastroesophageal reflux disease (GERD). The main objective of this Post Marketing Surveillance (PMS) cl...
Supported by the National Natural Science Foundation of China:the Study of Mucosa Repair Mechanism of Reflux Esophagitis Cure by the Method of Huoxuetongjiang(No.81573737);Mechanism of Huoxue Tongjiang Formula Treat Reflux Esophagitis based on the Effect of Esophageal Microbiome on TLR4/PAR2/TRPV1 Pathway(No.82074213)。
OBJECTIVE:To provide a basis for the clinical identification of true and false reflux,integrated traditional Chinese and Western medicine,and psychosomatic treatment,we conducted a retrospective study of the etiology ...
This study is registered at ClinicalTrials.gov.The registration identification number is NCT03736369。
BACKGROUND Fexuprazan,a novel potassium-competitive acid blocker,reversibly suppresses the K+/H+-ATPase enzyme in proton pumps within gastric parietal cells.Fexuprazan’s suppression of gastric acid was maintained in ...
Objective To evaluate the role of esophagogastric junction contractile index(EGJ-CI)in distinguishing patients with refractory gastroesophageal reflux disease(RGERD)from functional heartburn(FH).Methods From March 201...